Joel Stanley, the founder and former CEO of Charlotte’s Web, is leading an effort to achieve approval from the FDA for a ...

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...

The Health and Human Services Office of Inspector General has found that, in a few cases, FDA officials veered from the accelerated approval pathway.

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

Since joining Myeloma Canada's patient advisory council six years ago, he's known three people who have died waiting for a new drug to make its way through the approval process. Often ...

Chief Minister of Khyber Pakhtunkhwa, Ali Amin Khan Gandapur, has decided in principle to include the rehabilitation of drug addicts in the Sehat Card scheme and directed the relevant authorities to ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

The successful and safe delivery of therapeutics relies on understanding how easily drugs can pass through biological ...